|
Volumn 4, Issue 2, 2008, Pages 125-133
|
A vaccine against atherosclerosis: Myth or reality?
|
Author keywords
Atherosclerosis; Immunization; Inflammation; Vaccination
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
APOLIPOPROTEIN B100;
APOLIPOPROTEIN E;
BETA2 GLYCOPROTEIN 1;
CD25 ANTIBODY;
CD3 ANTIBODY;
CHOLESTEROL;
CHOLESTEROL ESTER TRANSFER PROTEIN;
DNA VACCINE;
HEAT SHOCK PROTEIN 60;
HEAT SHOCK PROTEIN 70;
HIGH DENSITY LIPOPROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMMUNOGLOBULIN G1 ANTIBODY;
IMMUNOGLOBULIN M ANTIBODY;
INTERLEUKIN 10;
INTERLEUKIN 12;
LIPID;
LOW DENSITY LIPOPROTEIN RECEPTOR;
MALONALDEHYDE;
MYELIN BASIC PROTEIN;
OXIDIZED LOW DENSITY LIPOPROTEIN;
PHOSPHORYLCHOLINE ANTIBODY;
PROTEIN ANTIBODY;
PROTEIN VACCINE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VACCINE;
VASCULOTROPIN RECEPTOR 2;
ALLERGIC ENCEPHALOMYELITIS;
ANGIOGENESIS;
ARTICLE;
ATHEROSCLEROSIS;
CHOLESTEROL BLOOD LEVEL;
HUMAN;
IMMUNOGENICITY;
IMMUNOLOGICAL TOLERANCE;
IMMUNOMODULATION;
INCIDENCE;
LIPID BLOOD LEVEL;
NONHUMAN;
PASSIVE IMMUNIZATION;
PRIORITY JOURNAL;
REGULATORY T LYMPHOCYTE;
VACCINATION;
|
EID: 40649109580
PISSN: 14796678
EISSN: 17448298
Source Type: Journal
DOI: 10.2217/14796678.4.2.125 Document Type: Article |
Times cited : (4)
|
References (52)
|